APO Research
Talk to an analyst

APO RESEARCH · REPORT

Felodipine Extended-Release Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Felodipine Extended-Release Tablets Industry Growth and Trends Forecast to 2032

27 December 2025109 pages

Choose your research edition.

Industry ResearchFelodipine Extended-Release Tablets Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Felodipine Extended-Release Tablets Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Felodipine Extended-Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Felodipine Extended-Release Tablets Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Felodipine Extended-Release Tablets Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Felodipine Extended-Release Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Felodipine Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Felodipine Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Felodipine Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Felodipine Extended-Release Tablets include By-Health, CSPC, Zhejiang Cheng Yi Pharmaceutical, Watsons, Schiff, Pfizer, Movefree, KAL and Doppelherz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Felodipine Extended-Release Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Felodipine Extended-Release Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Felodipine Extended-Release Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Felodipine Extended-Release Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Felodipine Extended-Release Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Felodipine Extended-Release Tablets Market by Company

By-Health

CSPC

Zhejiang Cheng Yi Pharmaceutical

Watsons

Schiff

Pfizer

Movefree

KAL

Doppelherz

Blackmores

AdvaCare

Felodipine Extended-Release Tablets Segment by Type

Tablets

Capsules

Felodipine Extended-Release Tablets Segment by Application

Hospital

Clinic

Pharmacy

Felodipine Extended-Release Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felodipine Extended-Release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Felodipine Extended-Release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felodipine Extended-Release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Felodipine Extended-Release Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Felodipine Extended-Release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablets Table 2. Major Company of Capsules Table 3. Global Felodipine Extended-Release Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Felodipine Extended-Release Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Felodipine Extended-Release Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Felodipine Extended-Release Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Felodipine Extended-Release Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Felodipine Extended-Release Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Felodipine Extended-Release Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Felodipine Extended-Release Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Felodipine Extended-Release Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Felodipine Extended-Release Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Felodipine Extended-Release Tablets Industry Trends Table 25. Felodipine Extended-Release Tablets Industry Drivers Table 26. Felodipine Extended-Release Tablets Industry Opportunities and Challenges Table 27. Felodipine Extended-Release Tablets Industry Restraints Table 28. Global Felodipine Extended-Release Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Felodipine Extended-Release Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Felodipine Extended-Release Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Felodipine Extended-Release Tablets Sales Share by Company (2021-2026) Table 32. Global Felodipine Extended-Release Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Felodipine Extended-Release Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Felodipine Extended-Release Tablets Major Company Production Sites and Headquarters Table 35. Global Felodipine Extended-Release Tablets Company, Product Type & Application Table 36. Global Felodipine Extended-Release Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Felodipine Extended-Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Felodipine Extended-Release Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Felodipine Extended-Release Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Felodipine Extended-Release Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Felodipine Extended-Release Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Felodipine Extended-Release Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Felodipine Extended-Release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Felodipine Extended-Release Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Felodipine Extended-Release Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Felodipine Extended-Release Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Felodipine Extended-Release Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Felodipine Extended-Release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Felodipine Extended-Release Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Felodipine Extended-Release Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Felodipine Extended-Release Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Felodipine Extended-Release Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Felodipine Extended-Release Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Felodipine Extended-Release Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Felodipine Extended-Release Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Felodipine Extended-Release Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Felodipine Extended-Release Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Felodipine Extended-Release Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. By-Health Company Information Table 72. By-Health Business Overview Table 73. By-Health Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. By-Health Felodipine Extended-Release Tablets Product Portfolio Table 75. By-Health Recent Development Table 76. CSPC Company Information Table 77. CSPC Business Overview Table 78. CSPC Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. CSPC Felodipine Extended-Release Tablets Product Portfolio Table 80. CSPC Recent Development Table 81. Zhejiang Cheng Yi Pharmaceutical Company Information Table 82. Zhejiang Cheng Yi Pharmaceutical Business Overview Table 83. Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product Portfolio Table 85. Zhejiang Cheng Yi Pharmaceutical Recent Development Table 86. Watsons Company Information Table 87. Watsons Business Overview Table 88. Watsons Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Watsons Felodipine Extended-Release Tablets Product Portfolio Table 90. Watsons Recent Development Table 91. Schiff Company Information Table 92. Schiff Business Overview Table 93. Schiff Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Schiff Felodipine Extended-Release Tablets Product Portfolio Table 95. Schiff Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Pfizer Felodipine Extended-Release Tablets Product Portfolio Table 100. Pfizer Recent Development Table 101. Movefree Company Information Table 102. Movefree Business Overview Table 103. Movefree Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Movefree Felodipine Extended-Release Tablets Product Portfolio Table 105. Movefree Recent Development Table 106. KAL Company Information Table 107. KAL Business Overview Table 108. KAL Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. KAL Felodipine Extended-Release Tablets Product Portfolio Table 110. KAL Recent Development Table 111. Doppelherz Company Information Table 112. Doppelherz Business Overview Table 113. Doppelherz Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Doppelherz Felodipine Extended-Release Tablets Product Portfolio Table 115. Doppelherz Recent Development Table 116. Blackmores Company Information Table 117. Blackmores Business Overview Table 118. Blackmores Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Blackmores Felodipine Extended-Release Tablets Product Portfolio Table 120. Blackmores Recent Development Table 121. AdvaCare Company Information Table 122. AdvaCare Business Overview Table 123. AdvaCare Felodipine Extended-Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. AdvaCare Felodipine Extended-Release Tablets Product Portfolio Table 125. AdvaCare Recent Development Table 126. North America Felodipine Extended-Release Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. North America Felodipine Extended-Release Tablets Sales by Country (2021-2026) & (K Units) Table 128. North America Felodipine Extended-Release Tablets Sales Market Share by Country (2021-2026) Table 129. North America Felodipine Extended-Release Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 130. North America Felodipine Extended-Release Tablets Sales Market Share Forecast by Country (2027-2032) Table 131. North America Felodipine Extended-Release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Felodipine Extended-Release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Felodipine Extended-Release Tablets Market Share by Country (2021-2026) Table 134. North America Felodipine Extended-Release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Felodipine Extended-Release Tablets Market Share Forecast by Country (2027-2032) Table 136. Europe Felodipine Extended-Release Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Europe Felodipine Extended-Release Tablets Sales by Country (2021-2026) & (K Units) Table 138. Europe Felodipine Extended-Release Tablets Sales Market Share by Country (2021-2026) Table 139. Europe Felodipine Extended-Release Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 140. Europe Felodipine Extended-Release Tablets Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Felodipine Extended-Release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Felodipine Extended-Release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Felodipine Extended-Release Tablets Market Share by Country (2021-2026) Table 144. Europe Felodipine Extended-Release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Felodipine Extended-Release Tablets Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Felodipine Extended-Release Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Felodipine Extended-Release Tablets Sales by Country (2021-2026) & (K Units) Table 148. Asia-Pacific Felodipine Extended-Release Tablets Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Felodipine Extended-Release Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 150. Asia-Pacific Felodipine Extended-Release Tablets Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Felodipine Extended-Release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Felodipine Extended-Release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Felodipine Extended-Release Tablets Market Share by Country (2021-2026) Table 154. Asia-Pacific Felodipine Extended-Release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Felodipine Extended-Release Tablets Market Share Forecast by Country (2027-2032) Table 156. Latin America Felodipine Extended-Release Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Latin America Felodipine Extended-Release Tablets Sales by Country (2021-2026) & (K Units) Table 158. Latin America Felodipine Extended-Release Tablets Sales Market Share by Country (2021-2026) Table 159. Latin America Felodipine Extended-Release Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 160. Latin America Felodipine Extended-Release Tablets Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Felodipine Extended-Release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Felodipine Extended-Release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Felodipine Extended-Release Tablets Market Share by Country (2021-2026) Table 164. Latin America Felodipine Extended-Release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Felodipine Extended-Release Tablets Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Felodipine Extended-Release Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Felodipine Extended-Release Tablets Sales by Country (2021-2026) & (K Units) Table 168. Middle East and Africa Felodipine Extended-Release Tablets Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Felodipine Extended-Release Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Felodipine Extended-Release Tablets Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Felodipine Extended-Release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Felodipine Extended-Release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Felodipine Extended-Release Tablets Market Share by Country (2021-2026) Table 174. Middle East and Africa Felodipine Extended-Release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Felodipine Extended-Release Tablets Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Felodipine Extended-Release Tablets Distributors List Table 179. Felodipine Extended-Release Tablets Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Felodipine Extended-Release Tablets Image Figure 2. Global Felodipine Extended-Release Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Felodipine Extended-Release Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Felodipine Extended-Release Tablets Sales (2021-2032) & (K Units) Figure 5. Tablets Image Figure 6. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 7. Capsules Image Figure 8. Global Capsules Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Felodipine Extended-Release Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Felodipine Extended-Release Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Felodipine Extended-Release Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Felodipine Extended-Release Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Felodipine Extended-Release Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Felodipine Extended-Release Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Felodipine Extended-Release Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Felodipine Extended-Release Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Felodipine Extended-Release Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Felodipine Extended-Release Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Felodipine Extended-Release Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Felodipine Extended-Release Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Felodipine Extended-Release Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Pharmacy Image Figure 28. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Felodipine Extended-Release Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Felodipine Extended-Release Tablets Market Share by Application 2025 VS 2032 Figure 31. North America Felodipine Extended-Release Tablets Sales Market Share in Volume by Application in 2025 Figure 32. North America Felodipine Extended-Release Tablets Sales Market Share in Value by Application in 2025 Figure 33. Europe Felodipine Extended-Release Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Felodipine Extended-Release Tablets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Felodipine Extended-Release Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Felodipine Extended-Release Tablets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Felodipine Extended-Release Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Felodipine Extended-Release Tablets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Felodipine Extended-Release Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Felodipine Extended-Release Tablets Sales Market Share in Value by Application in 2025 Figure 41. North America Felodipine Extended-Release Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Felodipine Extended-Release Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Felodipine Extended-Release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Felodipine Extended-Release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Felodipine Extended-Release Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Felodipine Extended-Release Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Felodipine Extended-Release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Felodipine Extended-Release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Felodipine Extended-Release Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Felodipine Extended-Release Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Felodipine Extended-Release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Felodipine Extended-Release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Felodipine Extended-Release Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Felodipine Extended-Release Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Felodipine Extended-Release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Felodipine Extended-Release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Felodipine Extended-Release Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Felodipine Extended-Release Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Felodipine Extended-Release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Felodipine Extended-Release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Felodipine Extended-Release Tablets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Felodipine Extended-Release Tablets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Hospital
  • Clinic
  • Pharmacy
Companies covered
  • By-Health
  • CSPC
  • Zhejiang Cheng Yi Pharmaceutical
  • Watsons
  • Schiff
  • Pfizer
  • Movefree
  • KAL
  • Doppelherz
  • Blackmores
  • AdvaCare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Felodipine Extended-Release Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Felodipine Extended-Release Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Felodipine Extended-Release Tablets Market by Type
  6. 1.3.1 Tablets
  7. 1.3.2 Capsules
  8. 1.4 Global Felodipine Extended-Release Tablets Market Size by Type
  9. 1.4.1 Global Felodipine Extended-Release Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Felodipine Extended-Release Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Felodipine Extended-Release Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Felodipine Extended-Release Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Felodipine Extended-Release Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Felodipine Extended-Release Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Felodipine Extended-Release Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Felodipine Extended-Release Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Felodipine Extended-Release Tablets Industry Trends
  2. 2.2 Felodipine Extended-Release Tablets Industry Drivers
  3. 2.3 Felodipine Extended-Release Tablets Industry Opportunities and Challenges
  4. 2.4 Felodipine Extended-Release Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Felodipine Extended-Release Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Felodipine Extended-Release Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Felodipine Extended-Release Tablets Price (2021-2026)
  4. 3.4 Global Felodipine Extended-Release Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Felodipine Extended-Release Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Felodipine Extended-Release Tablets Company, Product Type & Application
  7. 3.7 Global Felodipine Extended-Release Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Felodipine Extended-Release Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Felodipine Extended-Release Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Felodipine Extended-Release Tablets Tier 1, Tier 2, and Tier 3
4 Felodipine Extended-Release Tablets Regional Status and Outlook
  1. 4.1 Global Felodipine Extended-Release Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Felodipine Extended-Release Tablets Historic Market Size by Region
  3. 4.2.1 Global Felodipine Extended-Release Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Felodipine Extended-Release Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Felodipine Extended-Release Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Felodipine Extended-Release Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Felodipine Extended-Release Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Felodipine Extended-Release Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Felodipine Extended-Release Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Felodipine Extended-Release Tablets by Application
  1. 5.1 Felodipine Extended-Release Tablets Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Pharmacy
  5. 5.2 Global Felodipine Extended-Release Tablets Market Size by Application
  6. 5.2.1 Global Felodipine Extended-Release Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Felodipine Extended-Release Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Felodipine Extended-Release Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Felodipine Extended-Release Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Felodipine Extended-Release Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Felodipine Extended-Release Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Felodipine Extended-Release Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Felodipine Extended-Release Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 By-Health
  2. 6.1.1 By-Health Company Information
  3. 6.1.2 By-Health Business Overview
  4. 6.1.3 By-Health Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 By-Health Felodipine Extended-Release Tablets Product Portfolio
  6. 6.1.5 By-Health Recent Developments
  7. 6.2 CSPC
  8. 6.2.1 CSPC Company Information
  9. 6.2.2 CSPC Business Overview
  10. 6.2.3 CSPC Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSPC Felodipine Extended-Release Tablets Product Portfolio
  12. 6.2.5 CSPC Recent Developments
  13. 6.3 Zhejiang Cheng Yi Pharmaceutical
  14. 6.3.1 Zhejiang Cheng Yi Pharmaceutical Company Information
  15. 6.3.2 Zhejiang Cheng Yi Pharmaceutical Business Overview
  16. 6.3.3 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product Portfolio
  18. 6.3.5 Zhejiang Cheng Yi Pharmaceutical Recent Developments
  19. 6.4 Watsons
  20. 6.4.1 Watsons Company Information
  21. 6.4.2 Watsons Business Overview
  22. 6.4.3 Watsons Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Watsons Felodipine Extended-Release Tablets Product Portfolio
  24. 6.4.5 Watsons Recent Developments
  25. 6.5 Schiff
  26. 6.5.1 Schiff Company Information
  27. 6.5.2 Schiff Business Overview
  28. 6.5.3 Schiff Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Schiff Felodipine Extended-Release Tablets Product Portfolio
  30. 6.5.5 Schiff Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Felodipine Extended-Release Tablets Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Movefree
  38. 6.7.1 Movefree Company Information
  39. 6.7.2 Movefree Business Overview
  40. 6.7.3 Movefree Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Movefree Felodipine Extended-Release Tablets Product Portfolio
  42. 6.7.5 Movefree Recent Developments
  43. 6.8 KAL
  44. 6.8.1 KAL Company Information
  45. 6.8.2 KAL Business Overview
  46. 6.8.3 KAL Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 KAL Felodipine Extended-Release Tablets Product Portfolio
  48. 6.8.5 KAL Recent Developments
  49. 6.9 Doppelherz
  50. 6.9.1 Doppelherz Company Information
  51. 6.9.2 Doppelherz Business Overview
  52. 6.9.3 Doppelherz Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Doppelherz Felodipine Extended-Release Tablets Product Portfolio
  54. 6.9.5 Doppelherz Recent Developments
  55. 6.10 Blackmores
  56. 6.10.1 Blackmores Company Information
  57. 6.10.2 Blackmores Business Overview
  58. 6.10.3 Blackmores Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Blackmores Felodipine Extended-Release Tablets Product Portfolio
  60. 6.10.5 Blackmores Recent Developments
  61. 6.11 AdvaCare
  62. 6.11.1 AdvaCare Company Information
  63. 6.11.2 AdvaCare Business Overview
  64. 6.11.3 AdvaCare Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 AdvaCare Felodipine Extended-Release Tablets Product Portfolio
  66. 6.11.5 AdvaCare Recent Developments
7 North America by Country
  1. 7.1 North America Felodipine Extended-Release Tablets Sales by Country
  2. 7.1.1 North America Felodipine Extended-Release Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Felodipine Extended-Release Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Felodipine Extended-Release Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Felodipine Extended-Release Tablets Market Size by Country
  6. 7.2.1 North America Felodipine Extended-Release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Felodipine Extended-Release Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Felodipine Extended-Release Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Felodipine Extended-Release Tablets Sales by Country
  2. 8.1.1 Europe Felodipine Extended-Release Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Felodipine Extended-Release Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Felodipine Extended-Release Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Felodipine Extended-Release Tablets Market Size by Country
  6. 8.2.1 Europe Felodipine Extended-Release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Felodipine Extended-Release Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Felodipine Extended-Release Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Felodipine Extended-Release Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Felodipine Extended-Release Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Felodipine Extended-Release Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Felodipine Extended-Release Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Felodipine Extended-Release Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Felodipine Extended-Release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Felodipine Extended-Release Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Felodipine Extended-Release Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Felodipine Extended-Release Tablets Sales by Country
  2. 10.1.1 South America Felodipine Extended-Release Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Felodipine Extended-Release Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Felodipine Extended-Release Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Felodipine Extended-Release Tablets Market Size by Country
  6. 10.2.1 South America Felodipine Extended-Release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Felodipine Extended-Release Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Felodipine Extended-Release Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Felodipine Extended-Release Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Felodipine Extended-Release Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Felodipine Extended-Release Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Felodipine Extended-Release Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Felodipine Extended-Release Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Felodipine Extended-Release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Felodipine Extended-Release Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Felodipine Extended-Release Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Felodipine Extended-Release Tablets Value Chain Analysis
  2. 12.1.1 Felodipine Extended-Release Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Felodipine Extended-Release Tablets Production Mode & Process
  7. 12.2 Felodipine Extended-Release Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Felodipine Extended-Release Tablets Distributors
  10. 12.2.3 Felodipine Extended-Release Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst